BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FGF21
,
T cell receptor signaling pathway
,
Influenza
,
Lung
,
Autoimmunity
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pdgfr beta
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Livers 72hr post partial hepatectomy with hepatic stellate cell-specific b-PDGFR knockout
Liver stellate cells with GIPC1 shRNA knockdown treated with PDGFb
S17 stromal cell gene expression in response to treatment with PDGF-BB
Hepatic stellate cells from wildtype or PDGFRb knockout mice treated with PDGF-B
Hematopoietic stem cells expressing the TEL-PDGFRb gene fusion with and without imatinib treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
Establishment of extensive artificial intelligence models for kinase inhibitor prediction: Identific…
Corneal Vascularization Associated With a Novel PDGFRB Variant.
Concurrent PTEN and PDGFRB Alterations Characterize Storiform Collagenoma.
High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Pat…
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Meso…
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractor…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ